A new treatment option for poikiloderma of Civatte: 577 nm pro-yellow laser

Basit Öğe Kaydı
dc.authoridCenk, Hülya/0000-0003-4871-6342
dc.authorwosidCenk, Hülya/A-1293-2016
dc.contributor.authorSarac, Gulbahar
dc.contributor.authorKapicioglu, Yelda
dc.contributor.authorCenk, Hulya
dc.date.accessioned2024-08-04T20:50:54Z
dc.date.available2024-08-04T20:50:54Z
dc.date.issued2022
dc.departmentİnönü Üniversitesien_US
dc.description.abstractBackground Although many laser systems have been used in the treatment for Poikiloderma of Civatte (POC), there is no standard treatment guideline. Objectives We aimed to present our data on the efficacy and safety of single-session pro-yellow laser treatment for POC. Methods The study included 14 patients treated with pro-yellow laser (QuadroStarPRO YELLOW(R) Asclepion Laser Technologies, Germany) between 2017 and 2019. Treatment had been applied in two passes during the same session; a general pass with 22 j/cm(2) over the whole lesion, then, one more pass only on the telangiectatic lesions with 18 j/cm(2) fluence. They were evaluated based on their pictures taken before and 4 weeks after the treatment and scored by a 4-item scoring in terms of the improvement (0:no change, 1:1%-25% mild, 2:26%-50% moderate, 3:51%-75% well, and 4:76%-100% excellent improvement). Results The mean age of the patients (1 female, 13 males) was 59.64 +/- 8.16 years. Five patients had Fitzpatrick-2 and 9 patients had Fitzpatrick-3 skin types. Six patients had mild, 8 patients had moderate improvement, one of them has been illustrated in Figure 1. Sixty-minute mild erythema was the only adverse effect observed. Conclusions We think that pro-yellow laser is a good treatment option for POC treatment. Repeated sessions are required for the complete healing of the lesions, while one single session has proved to be deficient. We observed that it was a quite safe treatment option, especially for the neck region, which was inclined to scarring and atrophy development.en_US
dc.identifier.doi10.1111/jocd.14609
dc.identifier.endpage319en_US
dc.identifier.issn1473-2130
dc.identifier.issn1473-2165
dc.identifier.issue1en_US
dc.identifier.pmid34889036en_US
dc.identifier.scopus2-s2.0-85120823158en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage316en_US
dc.identifier.urihttps://doi.org/10.1111/jocd.14609
dc.identifier.urihttps://hdl.handle.net/11616/100352
dc.identifier.volume21en_US
dc.identifier.wosWOS:000728158700001en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.ispartofJournal of Cosmetic Dermatologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject577 nmen_US
dc.subjectpoikiloderma of civatteen_US
dc.subjectpro-yellow laseren_US
dc.subjectvascular laseren_US
dc.titleA new treatment option for poikiloderma of Civatte: 577 nm pro-yellow laseren_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu